Skin Cancer

The information below is intended for use by health care providers only. Please consult with your health care provider for more information about clinical trials.

Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk

To further evaluate the performance of DecisionDx-Melanoma in specific cohorts of subjects with primary cutaneous melanoma, including subjects with thin tumors less than 1mm in thickness with subsequent metastasis, and those with tumors identified as substage IIA, IIB, IIC, IIIA, IIIB, or IIIC.

Study Details

  • Study Site/Tumor Location: Melanoma
  • Study Location: Miami Valley Hospital
  • Ages eligible for study: 18 years and older
  • Genders eligible for study: Both
  • Principal Investigator: Dr. Jim Ouellette

Study Contact Information